health
May 8, 2026
Moderna pharmaceutical company confirms studies for hantavirus vaccine
The US pharmaceutical company Moderna announced this Friday that it is advancing preliminary research to develop a vaccine against hantavirus, a disease that has recently recaptured international attention after an outbreak on the cruise ship ‘MV Hondius’, where three people have died.
TL;DR
- Moderna is in the preclinical stage of developing a hantavirus vaccine.
- Research began before the recent outbreak on the cruise ship ‘MV Hondius’, where three deaths occurred.
- Moderna is collaborating with the U.S. Army Medical Research Institute of Infectious Diseases and Korea University.
- The company stated these efforts reflect its responsibility to develop countermeasures against emerging infectious diseases.
- Moderna's stock saw a significant rise of over 14% following the announcement.
- Hantavirus is transmitted by infected rodents and can cause severe respiratory complications.